{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-336681","form_type":"8-K","ticker":"GLUE","cik":"0001826457","company_name":"Monte Rosa Therapeutics, Inc.","filed_at":"2026-08-06T11:04:02+00:00","discovered_at":"2026-08-06T11:05:00.260856+00:00","generated_at":"2026-08-06T11:06:24.318881+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Monte Rosa Q2 2026 net loss $43.4M; cash $626M; MRT-8102 GFORCE-1 readout H2 2026","bullets":["Net loss of $43.4M in Q2 2026 vs $12.3M in Q2 2025; collaboration revenue $9.0M vs $23.2M.","Cash, equivalents, and marketable securities $626.0M as of June 30, 2026; expected to fund operations into 2029.","MRT-8102 GFORCE-1 study fully enrolled; readout of CRP and calprotectin data expected H2 2026.","Novartis activated Phase 2 study of MRT-6160 (DDY391) in Sjögren's disease; Monte Rosa eligible for milestone.","MODeFIRe-1 Phase 2 study of MRT-2359 in mCRPC with AR mutations activated; first patient dosing expected Q3 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-336681","json":"https://secwatch.observer/filing/0001193125-26-336681.json","markdown":"https://secwatch.observer/filing/0001193125-26-336681.md","text":"https://secwatch.observer/filing/0001193125-26-336681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826457/000119312526336681/0001193125-26-336681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826457/000119312526336681/glue-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:06:24.318881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}